Literature DB >> 8653871

Glucose uptake in the chronically dysfunctional but viable myocardium.

M Mäki1, M Luotolahti, P Nuutila, H Iida, L M Voipio-Pulkki, U Ruotsalainen, M Haaparanta, O Solin, J Hartiala, R Härkönen, J Knuuti.   

Abstract

BACKGROUND: The regulation of glucose uptake in the dysfunctional but viable myocardium has not been studied previously in humans. METHODS AND
RESULTS: Seven patients with an occluded major coronary artery but no previous infarction were studied twice with 2-[(18)F]fluoro-2-deoxy-D-glucose positron emission tomography, once in the fasting state and once during hyperinsulinemic euglycemic clamping. Myocardial blood flow was measured with [(15)O]H2O. The myocardial region beyond an occluded artery that showed stable wall-motion abnormality represented chronically dysfunctional but viable tissue. Six of the patients were later revascularized, and wall-motion recovery was detected in the corresponding regions, which confirmed viability. A slightly reduced myocardial blood flow was detected in the dysfunctional than in the remote myocardial regions (0.81 +/- 0.27 versus 1.02 +/- 0.23 mL x g(-1) x min(-1),P=.036). In the fasting state, glucose uptake was slightly increased in the dysfunctional regions compared with normal myocardium (15 +/- 10 versus 11 +/- 10 micromol/100 g per minute, P=.038). During insulin clamping, a striking increase in glucose uptake by insulin was obtained in both the dysfunctional and the normal regions (72 +/- 22 and 79 +/- 21 micromol/100 g per minute, respectively; P<.001, fasting versus clamping).
CONCLUSIONS: Contrary to previous suggestions, glucose uptake can be increased strikingly by insulin in chronically dysfunctional but viable myocardium. This demonstrates that insulin control over glucose uptake is preserved in the dysfunctional myocardium and provides a rational basis for metabolic intervention.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8653871     DOI: 10.1161/01.cir.93.9.1658

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  26 in total

1.  PET myocardial perfusion and glucose metabolism imaging: Part 2-Guidelines for interpretation and reporting.

Authors:  Heinrich R Schelbert; Robert Beanlands; Frank Bengel; Juhani Knuuti; Marcelo Dicarli; Josef Machac; Randolph Patterson
Journal:  J Nucl Cardiol       Date:  2003 Sep-Oct       Impact factor: 5.952

Review 2.  Targeted metabolic imaging to improve the management of heart disease.

Authors:  Moritz Osterholt; Shiraj Sen; Vasken Dilsizian; Heinrich Taegtmeyer
Journal:  JACC Cardiovasc Imaging       Date:  2012-02

Review 3.  Molecular and cellular basis of viable dysfunctional myocardium.

Authors:  Marina Bayeva; Konrad Teodor Sawicki; Javed Butler; Mihai Gheorghiade; Hossein Ardehali
Journal:  Circ Heart Fail       Date:  2014-07       Impact factor: 8.790

4.  Effects of glucose-insulin-potassium infusion on chronic ischaemic left ventricular dysfunction.

Authors:  V K Khoury; B Haluska; J Prins; T H Marwick
Journal:  Heart       Date:  2003-01       Impact factor: 5.994

5.  Unsuspected hibernating myocardium detected by routine oncology (18)F-FDG PET/CT.

Authors:  Didier Vilain; Jean Bochet; Elise Le Stanc; Clement Wattel; Amine Hameg; Catherine Tainturier
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12-09       Impact factor: 9.236

6.  Under the hood of the stunned takotsubo heart.

Authors:  Pradeep Bhambhvani
Journal:  J Nucl Cardiol       Date:  2017-02-10       Impact factor: 5.952

7.  An abbreviated hyperinsulinemic-euglycemic clamp results in similar myocardial glucose utilization in both diabetic and non-diabetic patients with ischemic cardiomyopathy.

Authors:  James A Fallavollita; Andrew J Luisi; Edward Yun; Robert A deKemp; John M Canty
Journal:  J Nucl Cardiol       Date:  2010-04-14       Impact factor: 5.952

Review 8.  Tracing cardiac metabolism in vivo: one substrate at a time.

Authors:  Heinrich Taegtmeyer
Journal:  J Nucl Med       Date:  2010-04-15       Impact factor: 10.057

9.  Coronary blood flow, metabolism, and function in dysfunctional viable myocardium before and early after surgical revascularisation.

Authors:  F Alamanni; A Parolari; A Repossini; E Doria; F Bortone; J Campolo; M Pepi; E Sisillo; M Naliato; R Bigi; P Biglioli; O Parodi
Journal:  Heart       Date:  2004-11       Impact factor: 5.994

10.  Insulin improves postischemic recovery of function through PI3K in isolated working rat heart.

Authors:  Vlad Zaha; Ieda Francischetti; Torsten Doenst
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.